JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'signaling pathways pi3k akt mtor signaling pi3k zstk474'

Search results for: 'signaling pathways pi3k akt mtor signaling pi3k zstk474'

A1877 XAV-939
1 Citation

Target: TNKS

Summary: Tankyrase 1/2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
A3004 Vemurafenib (PLX4032, RG7204)
9 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥24.5 mg/mL
A8217 ICG 001
1 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A8330 CX-4945 (Silmitasertib)
9 Citation

Summary: CK2 inhibitor

≥103.5 mg/mL
A3133 A 83-01

Summary: ALK-5 inhibitor

≥21.1 mg/mL
A3009 Sorafenib
2 Citation

Target: Raf|VEGFR

Summary: Raf kinases and tyrosine kinases inhibitor

≥23.25 mg/mL
L1034 DiscoveryProbe™ PI3K/Akt/mTOR Compound Library

Summary: A unique collection of 178 PI3K/Akt/mTOR inhibitors for PI3K/Akt/mTOR signaling pathway research.
A9904 AKT/mTOR Set I

Summary: For inhibiting AKT/mTOR
BA7284 IHMT-PI3Kδ-372

Summary: IHMT-PI3Kδ-372 is a potent and selective inhibitor.
BA3287 PI3Kδ-IN-16

Summary: PI3Kδ-IN-16 is a potent and selective inhibitor.